No direction has benn indicated or value assigned to the clinical programs or the intellectual property. No indication of the monetization of tax issues. This should be revealed. I doubt they have overlooked it.
ENZN will trade higher after BIG MONEY analyzes and breaks down the future revenue stream for all the royalties received. Right now people are selling because they don't understand the deal. Ichan and his cronies are no dummies.